Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029536 · ClinicalTrials.gov registry record · Phase 3
Progesterone vs Placebo Therapy for Women With Epilepsy
A Phase 3 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 294
- Enrollment target
NCT00029536: Completed Phase 3 study, sponsored by Beth Israel Deaconess Medical Center.
NCT00029536 is a Phase 3 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 294 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029536, a Phase 3 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 294 participants
- Enrollment target
Study Summary
The purpose of this investigation was to determine if cyclic adjunctive progesterone supplement is superior to placebo in the treatment of intractable seizures in women with and without catamenial epilepsy.
Primary Outcome
Percent of women who show a greater than 50% decline in average daily seizure frequency
Interventions
- BIOLOGICAL Progesterone Lozenges
- OTHER Matched Placebo Lozenges
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2000-10 |
| Est. Completion | 2010-06 |
| Phase | Phase 3 |
What the finished NCT00029536 record still lists
NCT00029536 is an interventional study that assigns participants to a tested intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 2 interventions - of which Progesterone Lozenges is the first listed.
NCT00029536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00029536 about?
NCT00029536 is a clinical study titled "Progesterone vs Placebo Therapy for Women With Epilepsy". The purpose of this investigation was to determine if cyclic adjunctive progesterone supplement is superior to placebo in the treatment of intractable seizures in women with and without catamenial epilepsy.
What is the current status of trial NCT00029536?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 294 participants. The study started on 2000-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00029536?
The interventions under investigation include: Progesterone Lozenges (BIOLOGICAL), Matched Placebo Lozenges (OTHER).
Who is sponsoring clinical trial NCT00029536?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00029536's enrollment target sits among peer trials
294 1166th of 2000 higher than 835 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia